Autopsy report · NCT03060473

Treatment of ppROM With Erythromycin vs. Azithromycin Trial

“Patient population that meets study criteria is insufficient to continue project in a reasonable amount of time. To continue is futile in resources, staff time, and effort.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 years 10 months before it stopped.
• 21 participants enrolled.
• Results were posted on the registry 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

The University of Texas Medical Branch, Galveston

Sponsor type

University, hospital or other

Conditions

Preterm Premature Rupture of Membranes (PPROM)

Interventions

Azithromycin; Erythromycin; Ampicillin; Amoxicillin

Participants

21

Sites

3

Countries

United States

Trials that died the same way

• The Dallas Hereditary Spherocytosis Cohort Study
  “Insufficient staff to continue pursuing project” (69% match in meaning)
• All-On-4® Treatment Concept
  “The study stopped as the performance of the study showed insufficient patient recruitment.” (64% match in meaning)
• Metformin and Transient Hyperglycemia
  “The research project was terminated due to lower than projected patient recruitment within the period of time allowed for the study.” (64% match in meaning)
• Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)
  “Study terminated due to lack of feasibility of study design.” (62% match in meaning)
• Fesoterodine on Urgency Episodes in Parkinson's Disease Population
  “Insufficient or untimely patient recruitment” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.